DAVI (DAVI)

NASDAQ: DAVI · USD

$1.51

-0.03 (-1.9%)· Recorded snapshot

Market cap	37.8M
Net income (ttm)	-967.5K
EPS (ttm)	-$0.04
Shares out	25M
Volume	125,104

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -967.5K
EPS (ttm): -$0.04
Market cap: 37.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 20:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-1.3

P25 n/aP50 n/aP75 n/a

ROIC-0.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All DAVI indicators

Market & fundamental data

Available fields

117

Groups with data

Currency

EUR

Showing 117 of 117 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0002039072
Country	Ireland
Country code	US
Earnings date	2027-04-06
Enterprise value	$38.8M
Exchange	NASDAQ
Financial currency	EUR
Financial report date	2025-12-31
First seen	2026-10-22
Fiscal year end	December
Founded	2022
Industry	Medical Instruments & Supplies
Is primary listing	Yes
Is SPAC	No
ISIN number	IE000GVCI8S8
Last 10-K release date	2026-04-30
Last refreshed	2026-11-04
Last stock split type	Never
Market cap	$37.8M
Market cap category	Nano-Cap
Next earnings date	2027-04-06
Price	$1.51
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-11-04
Symbol	DAVI
Website	https://www.davionhealthcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-2.56%
Industry forward P/E	24.06x
Industry P/E	66.71x
P/B ratio	0.51x
Sector forward P/E	24x
Sector P/E	49.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-0.79%
ROCE	-1.27%
ROE	-1.28%
ROIC	-0.79%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Net income growth years	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	$-967,450
EPS	$-0.04
Financing cash flow	$1,609
Net borrowing	$1,541
Net cash flow	$1,229
Net income	$-967,450
Operating income	$-967,450

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$3.01
Debt / equity	0.01
Long-term assets	$76.3M
Long-term liabilities	$1.1M
Net cash (debt)	$-1.1M
Net cash / market cap	-2.76%
Net debt / equity	0.01
Piotroski F-Score	2
Shareholders' equity	$75.3M
Tangible book value	$-1M
Tangible book value per share	$-0.04
Total assets	$76.5M
Total cash	$1,242
Total debt	$1.1M
Total liabilities	$1.2M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$158,151
Current liabilities	$99,561
Current ratio	1.59
Net working capital	$59,914
Quick ratio	0.2
Working capital	$61,157

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-9.12%
Dividend yield	0%
Shareholder yield	-9.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	-1.95%
1W price change	-53.19%
1W total return	-53.19%
52-week high	$12.30
52-week high date	2026-10-22
52-week low	$1.40
52-week low date	2026-11-03
After-hours change	-1.95%
After-hours close	$1.54
After-hours price	$1.51
All-time high	$12.30
All-time high date	2026-10-22
All-time low	$1.40
All-time low date	2026-11-03
Average volume	2.3M
Change from 52-week high	-87.72%
Change from 52-week low	7.86%
Change from all-time high	-87.48%
Change from all-time low	10%
Change from open	-6.21%
Day's gap	4.55%
Dollar volume	$188,907
High price	$1.63
Low price	$1.50
Monthly RSI	0
Open price	$1.61
Position in 52-week range	7.69%
Premarket change	0%
Premarket close	$1.54
Premarket price	$1.54
Previous close	$1.54
Relative volume	0.06
Return from IPO price	-87.17%
RSI	0
Sharpe ratio	-15.14
Sortino ratio	-11.05
Volume	125.1K
Weekly RSI	0

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.2M
Float percentage	12.84%
Shares change (QoQ)	0%
Shares change (YoY)	9.12%
Shares held by insiders	87.16%
Shares outstanding	25M

Deeper analysis on DAVI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DAVI report

Is a complete DAVI research report available?

No complete published report is available for DAVI (DAVI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DAVI (DAVI)

Price

Financial snapshot

Fair-value bridge

Latest news · DAVI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DAVI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DAVI

Frequently asked questions